Company Filing History:
Years Active: 2021-2024
Title: Geun Ho An: Innovator in Fibrosis Treatment
Introduction
Geun Ho An is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of fibrosis. With a total of 2 patents to his name, his work is paving the way for innovative therapeutic solutions.
Latest Patents
Geun Ho An's latest patents focus on compositions and methods for treating or preventing fibrosis. The first patent relates to compositions and methods comprising polypeptides derived from MFG-E8 for treating and preventing fibrosis and other diseases. The second patent introduces a recombinant protein for preventing or treating tissue fibrosis, which is based on milk fat globule-EGF factor 8 (MFG-E8) protein. This recombinant protein significantly improves the effectiveness of preventing or treating tissue fibrosis compared to conventional methods. The invention aims to restore tissue fibrosis levels to those very close to normal tissue, showcasing its potential impact on medical treatments.
Career Highlights
Geun Ho An is associated with Nexel Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health issues related to fibrosis.
Collaborations
Geun Ho An collaborates with notable colleagues, including Choong Seong Han and Dong Hun Woo. Their combined expertise enhances the research and development efforts at Nexel Co., Ltd.
Conclusion
Geun Ho An's contributions to the field of fibrosis treatment through his innovative patents highlight his role as a leading inventor in medical research. His work promises to make a significant difference in the lives of those affected by fibrosis.